연구동향 분석

Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study

Jae Hun Shim Se Young Choi Joon Hee Gook Yong-June Kim Woo Heon Cha Dae Hee Kim Kyeong Hee Kim Young Woong Park Jin Mo Um Il Sung Lim Kyung Keun Seo Kyu Seon Cho Young Jae Lee Mi-Kyung Lee Tae-Hyoung Kim 2021년

논문상세정보
인용/피인용
' Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Solifenacin succinate
  • overactive
  • urinary bladder
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
70 0

0.0%

' Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study' 의 참고문헌

  • What are factors contributing to improvement of overactive bladder symptoms after alpha-1 blocker treatment in patients with both storage and voiding symptoms?
    Matsukawa Y [2019]
  • The standardization of terminology of lower urinary tract function in children and adolescents : update report from the standardization committee of the International Children’s Continence Society
    Austin PF [2016]
  • The psychological impact of overactive bladder : a systematic review
    Kinsey D [2016]
  • The effect of oral solifenacin succinate treatment on intraocular pressure : glaucoma paradox during overactive bladder treatment
  • The association between overactive bladder and falls and fractures : a systematic review
    Szabo SM [2018]
  • Test-retest reliability of four questionnaires for patients with overactive bladder : the overactive bladder questionnaire(OAB-q), patient perception of bladder condition(PPBC), urgency questionnaire(UQ), and the primary OAB symptom questionnaire(POSQ)
    Matza LS [2005]
  • Solifenacin in the elderly : results of an observational study measuring efficacy, tolerability and cognitive effects
    Hampel C [2017]
  • Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placeboand tolterodine-controlled phase 2 dose-finding study
    Chapple CR [2004]
  • Severe depression and anxiety in women with overactive bladder
    Melotti IGR [2018]
  • Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study
    Lee YS [2011]
  • Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries:results of the EPIC study
    Irwin DE [2006]
  • OAB Study Group in Northern Hokkaido. Efficacy and safety of propiverine and solifenacin for the treatment of female patients with overactive bladder: a crossover study
    Wada N [2011]
  • Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder
    Wang J [2019]
  • Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder : a randomised, multicentre phase 3 study(SYNERGY II)
    Gratzke C [2018]
  • How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study
    Milsom I [2001]
  • Efficacy and tolerability of solifenacin in men with overactive bladder : results of an observational study
    Burger M [2014]
  • Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms
    김연주 [2020]
  • A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial
    Chapple CR [2005]